Clinical Trials · NCT05369390
A Research Study on How NNC0487-0111 Works in People With Overweight or Obesity
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 144
- Start date
- May 2022
- Locations
- 2 sites, United States
- Primary endpoint
- Number of treatment emergent adverse events (TEAE)